AstraZeneca Gets FDA Approval in Boost to Rare Disease Franchise 4/1/2024

Biogen and Eisai Fall Behind on Leqembi’s Subcutaneous BLA for Alzheimer’s 4/1/2024

BMS Pulls Ahead of Amgen, Aces Confirmatory Phase III NSCLC Trial for Krazati 4/1/2024

Lack of Medicare Coverage for GLP-1 Drugs Tied to Lower Prescription Rates: Study 4/1/2024

Fractyl Secures FDA Approval for Weight Maintenance Study After Discontinuation of GLP-1s 4/1/2024

Will Oral Weight-Loss Drugs Break Open an Already Lucrative Market? 4/1/2024

Psychosis: The Other Big Alzheimer’s Therapeutic Target 4/1/2024

6 Recently Approved Cell & Gene Therapies—And Why They Matter 4/1/2024

FDA Action Alert: Vanda, Basilea and J&J/Legend 4/1/2024

Could healthy fats found in nuts and fish slow the progression of potentially deadly lung scarring known as pulmonary fibrosis and delay the need for lung transplants?

UVA pulmonary researchers looked at the association between blood-plasma levels of omega-3 fatty acids - the heart-healthy fats found in foods such as salmon and flaxseeds - and the progression of pulmonary fibrosis, as well as how long patients could go without needing a transplant.

A previously unidentified genetic mutation in a small protein provides significant protection against Parkinson's disease and offers a new direction for exploring potential treatments, according to a new USC Leonard Davis School of Gerontology study.

The variant, located in a mitochondrial microprotein dubbed SHLP2, was found to be highly protective against Parkinson’s disease; individuals with this mutation are half as likely to develop the disease as those who do not carry it.

A new study published in Addiction has found that cytisine, a low-cost, generic stop-smoking aid that has been used in eastern Europe since the 1960s, increases the chances of successful smoking cessation by more than two-fold compared with placebo and may be more effective than nicotine replacement therapy. It has a benign safety profile, with no evidence of serious safety concerns.